SHIONOGI
Shionogi & Co., Ltd. is a Japan-based pharmaceutical company. It is engaged in the research, development, purchase, manufacture and sale of pharmaceuticals, as well as pharmaceutical-related businesses. The Company mainly provides vitamin preparations, analgesic antipyretics, cold and sinus medicine, digestive medicine, dermatologic preparations, antiphlogistic analgetics, antihypercholesterolemic agents, test paper for glucose in urine and artificial teeth-related products.
SHIONOGI
Industry:
Biotechnology Medical Pharmaceutical
Founded:
1878-03-17
Address:
Osaka-shi, Osaka, Japan
Country:
Japan
Website Url:
http://www.shionogi.com
Total Employee:
10001+
Status:
Active
Contact:
+81662022161
Total Funding:
7.6 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics Apple Mobile Web Clips Icon Google Tag Manager Domain Not Resolving Apache Global Site Tag
Similar Organizations
Aspen Pharmacare
Aspen Pharmacare is a global supplier of branded and generic pharmaceutical products.
Bayer
Bayer is a life science company that specializes in the areas of health care and agriculture.
Becton Dickinson India
BD is a global medical technology company that is advancing the world of health by improving medical discovery.
Boehringer Ingelheim
Boehringer Ingelheim is a global group of companies embracing many cultures and diverse societies.
British Army
British Army is the principal land warfare force of the United Kingdom.
Dongwha Pharm
Dongwha Pharm offers drugs such as antipyretics, analgesics, and antibiotics for cardiovascular, and alimentary ailments.
Guangyuyuan
GuangYuYuan Chinese Herbal Medicine Co., Ltd. develops and manufactures Chinese raw material medicines as well as advertising services.
Hisamitsu Pharmaceutical
Hisamitsu Pharmaceutical is a medical product company that offers a pain relief patch.
KNMP
KNMP is the Royal Dutch Society for the Promotion of Pharmacy is the umbrella professional and branch organization of pharmacists.
Mallinckrodt
Their evolution as a company starts now, and they are poised for an exciting future. Their core strengths provide the impetus for future
Meiji Holdings
Meiji Holdings provides disaster relief through donations and contributions to people/businesses in need.
Novo Nordisk
Novo Nordisk is a global healthcare company with more than 90 years of innovation and leadership in diabetes care.
Teva Pharmaceutical Industries
Teva Pharmaceutical Industries is a pharmaceutical company specializing in the development, production and marketing of generic.
TTY Biopharm
TTY Biopharm is to improve the quality of human life with scientific innovation.
University of California, San Francisco
Director of the Lab for Advanced Cytometry (LAC) and the Sony Biotechnology Center at UCSF in the Department of Laboratory Medicine
Zhongyuan Union Cell & Gene Eng
Zhongyuan Union Cell & Gene Eng is principally engaged in the detection and storage of stem cell sources.
Walgreens
Walgreens is a pharmacy, health, and wellness service center that offers trained infusion nurses and pharmacists to treat patients.
Current Employees Featured
Jimmy Chen Senior Director, Pharmaceutical Sciences @ Shionogi
Senior Director, Pharmaceutical Sciences
2013-09-01
Ed Schutter President and Chief Operating Officer @ Shionogi
President and Chief Operating Officer
Lance Bennett KAM Leader, West Region @ Shionogi
KAM Leader, West Region
2020-10-01
Suzie Henderson Senior Submission Manager, Regulatory Affairs @ Shionogi
Senior Submission Manager, Regulatory Affairs
2019-05-01
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2020-05-26 | Tetra Therapeutics | Tetra Therapeutics acquired by Shionogi | N/A |
| 2008-09-02 | Shionogi Pharma Inc. | Shionogi Pharma Inc. acquired by Shionogi | 1.4 B USD |
Investors List
CARB-X
CARB-X investment in Grant - Shionogi
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2021-05-26 | Akili Interactive Labs | Shionogi investment in Series D - Akili Interactive Labs | 110 M USD |
| 2019-05-07 | Aillis | Shionogi investment in Venture Round - Aillis | 1.25 B JPY |
| 2019-01-15 | Vast Therapeutics | Shionogi investment in Series A - Vast Therapeutics | 15 M USD |
| 2018-10-05 | FunPep | Shionogi investment in Venture Round - FunPep | 460 M JPY |
| 2018-04-18 | PeptiStar | Shionogi investment in Corporate Round - PeptiStar | 20 B JPY |
| 2015-10-27 | FunPep | Shionogi investment in Venture Round - FunPep | 50 M JPY |
| 2014-12-15 | StemRIM | Shionogi investment in Corporate Round - StemRIM | 800 M JPY |
| 2004-01-16 | Peninsula Pharmaceuticals | Shionogi investment in Series C - Peninsula Pharmaceuticals | 57.9 M USD |
Official Site Inspections
http://www.shionogi.com Semrush global rank: 245.61 K Semrush visits lastest month: 284.92 K
- Host name: 238.41.180.107.host.secureserver.net
- IP address: 107.180.41.238
- Location: Scottsdale United States
- Latitude: 33.6013
- Longitude: -111.8867
- Metro Code: 753
- Timezone: America/Phoenix
- Postal: 85260
More informations about "Shionogi"
About Us | Shionogi Inc.
Shionogi Inc. is the U.S. subsidiary of Shionogi & Co., Ltd., a 140-year-old global pharmaceutical company with headquarters in Osaka, Japan. In the U.S., Shionogi Inc. leverages our science …See details»
Corporate Governance System - Shionogi & Co., Ltd.
To ensure directors and each organization in the Company conduct their duties in a legally compliant and appropriate manner, the Company has established systems to enable corporate auditors and the Internal Control Department, …See details»
Shionogi - Crunchbase Company Profile & Funding
Shionogi is working on antifungal agents to address unmet needs caused by drug-resistant aspergillus and other rare mould infections. Women's Health: …See details»
Bob Marino - VP Of Business Development At Shionogi …
Shionogi Inc. is the U.S. subsidiary of Shionogi & Co., Ltd., a 140-year-old global pharmaceutical company with headquarters in Osaka, Japan. In the U.S., …See details»
Shionogi - Wikipedia
Shionogi & Company, Limited (塩野義製薬株式会社, Shionogi Seiyaku Kabushiki Kaisha) is a Japanese pharmaceutical company best known for developing Crestor.Medical supply and …See details»
Corporate Governance | About Shionogi | Shionogi & Co., Ltd.
Shionogi has aimed to fulfill its corporate mission-Continually providing the superior medicines essential to people's health. TOP > About Shionogi > Corporate Governance; Corporate …See details»
CEO and Executive Team - The Org
About. Shionogi's CEO and Executive Team includes Joseph Spagnardi and 5 others.See details»
Company Profile | About Shionogi | Shionogi & Co., Ltd.
Mar 31, 2024 Corporate Name: Shionogi & Co., Ltd. Chief Executives: Isao Teshirogi, Ph.D., Representative Director, President and CEO: Established: March 17, 1878: IncorporatedSee details»
Medical Information - SHIONOGI U.S. Medical
The site is made available by Shionogi's U.S. Medical Affairs organization, and is provided as a scientific resource for informational, non-promotional purposes. This site may contain …See details»
Shionogi - The Org
Shionogi Inc. is the U.S. subsidiary of Shionogi & Co., Ltd., a 140-year-old global pharmaceutical company with headquarters in Osaka, Japan. In the U.S., Shionogi Inc. leverages their science-based heritage to develop and …See details»
Shionogi Inc. - A Discovery-Based Pharmaceutical Company
Shionogi Inc. is dedicated to advancing the greater good by developing, partnering, and commercializing medicine to treat serious unmet medical needs. Shionogi Inc. - A Discovery …See details»
Shionogi & Co.,Ltd. - The Valuable 500
Shionogi & Co.,Ltd.’s Valuable 500 Commitment: Respect human rights. ... We aspire to be an organization where barriers to communication and barriers to accessibility are removed, and …See details»
Shionogi - Clinical Research and Data Management - The Org
The Clinical Research and Data Management team at Shionogi plays a crucial role in designing, implementing, and overseeing clinical trials to ensure the safety and efficacy of pharmaceutical …See details»
Shionogi Company Profile - Office Locations, Competitors ... - Craft
Oct 29, 2024 Shionogi has 5 employees across 23 locations and ¥410.07 b in annual revenue in FY 2024. See insights on Shionogi including office locations, competitors, revenue, financials, …See details»
Medical Congresses - SHIONOGI U.S. Medical
The site is made available by Shionogi's U.S. Medical Affairs organization, and is provided as a scientific resource for informational, non-promotional purposes. This site may contain …See details»
Philosophy | About Shionogi | Shionogi & Co., Ltd.
The purpose of the SHIONOGI Group's corporate activities is, as expressed in the opening of "The Company Policy of SHIONOGI", to "supply the best possible medicine to protect the …See details»
History and Global Brand - Shionogi
We established Shionogi USA, Inc. (now Shionogi Inc.) and formed a joint venture with the UK-based GlaxoSmithKline (GSK) to collaborate on research and development, focusing on HIV …See details»
Welcome to Shionogi U.S. Medical
The site is made available by Shionogi's U.S. Medical Affairs organization, and is provided as a scientific resource for informational, non-promotional purposes. This site may contain …See details»
HCP Resources - SHIONOGI U.S. Medical
The site is made available by Shionogi's U.S. Medical Affairs organization, and is provided as a scientific resource for informational, non-promotional purposes. This site may contain …See details»
Exclusive Licensing Agreement with Link Healthcare, a Clinigen …
OSAKA, Japan, April 2 , 2025 - Shionogi & Co., Ltd. (Head Office: Osaka, Japan; Chief Executive Officer: Isao Teshirogi, Ph.D.; hereinafter "Shionogi") is pleased to announce that it has …See details»